Ann: Change in substantial holding, page-13

AXP has never raised capital at $1.65; on 8 Jun 16 they raised A$20M at $0.76 and on 27 Jan 17 they raised A$45M at $0.93.

The aeroform value proposition is exceptional and should apply in every jurisdiction . My analysis says that sales seasonality for the March Qtr has masked underlying unit sales growth (I put that analysis with reference in another thread). Seasonality will work in their favour for the Jun Qtr and unit sales of 900 are easily achievable.

AXP are not able to commission a suitably experienced 3rd party sales force (like NAN and GE) because Aeroform sales would cannibalise the 3rd party's own expander sales. I suspect the AXP Principals shopped the technology to the "big boys" but were asking too much money so were forced to commercialise Aeroform.


AXP Management has made a huge mess of strategy implementation. Cash burn has become critical; currently they have a staff level around 124 (from the 2017 AR) and a wage level 3 times annual sales.

Management needs to slash costs and push sales - simple!